You are here

  • Home
  • Archive
  • Volume 14, Issue 6
  • HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization

Article metrics

Article menu
Download PDFPDF
Original Articles
HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019801
Mar 2019200
Apr 2019600
May 20191000
Jul 2019200
Aug 2019200
Oct 2019200
Nov 2019601
Dec 2019400
Jan 20201000
Feb 2020400
Mar 2020100
Apr 2020200
May 20201000
Jun 2020600
Jul 2020800
Aug 2020200
Sep 2020600
Oct 2020600
Nov 2020200
Dec 2020800
Jan 2021200
Feb 2021401
Apr 2021200
May 2021200
Oct 2021800
Nov 2021200
Dec 2021200
Jan 20221400
Feb 20221400
Mar 20221200
Apr 20221000
May 20223402
Jun 20223200
Jul 20221600
Aug 20224400
Sep 20223600
Oct 20223600
Nov 20221200
Dec 2022800
Jan 2023800
Feb 20234800
Mar 2023300
Apr 2023300
May 2023200
Jun 20231000
Jul 2023400
Aug 20231601
Sep 2023200
Oct 2023800
Nov 20231100
Dec 20231700
Jan 2024200
Feb 2024400
Mar 2024300
Apr 20241202
Total55008